Trials / Recruiting
RecruitingNCT05415007
GOLD: Brief Intervention to Reduce Anxiety and Promote Resilience in Families of Youth With Cancer
Brief Intervention to Reduce Anxiety and Promote Resilience in Caregivers of Youth With Cancer
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Stanford University · Academic / Other
- Sex
- All
- Age
- 8 Years – 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to examine a psychotherapeutic and psycho-educational intervention offered in virtual settings to caregivers of youth with cancer. Human subjects must be used because they are the object of the intervention.
Detailed description
PRIMARY OBJECTIVE(S)- To examine the feasibility and accessibility of a brief intervention for caregivers of youth with newly-diagnosed cancer as a preliminary, data-generating step toward applying for a larger NCI R34 grant evaluating the efficacy of the program in a randomized controlled trial. SECONDARY OBJECTIVE(S)- We hope to learn whether a psycho-educational, psychotherapeutic intervention offered in a virtual setting to caregivers of children diagnosed with cancer is feasible, is acceptable, and can prevent, minimize, or improve symptoms of psychological distress (including symptoms of anxiety, depression, and post-traumatic stress disorder). We also hope to further our understanding of family stress and expand the idea for a need of mental health services in pediatric oncology. We aim to further understand intervention strategies for domains of family stress, reducing levels of caregiver anxiety, and promoting resilience for caregivers. This is important because these symptoms can affect the quality of life of caregivers and affect their ability to adhere to their children's treatments.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | GOLD Program | Participant will receive a 2-hour interventional session |
| BEHAVIORAL | Treatment as usual (TAU) | Participant will receive treatment-As-Usual which consist of information about diagnosis routinely-disseminated by personnel and providers. |
Timeline
- Start date
- 2022-09-21
- Primary completion
- 2026-12-31
- Completion
- 2027-06-30
- First posted
- 2022-06-10
- Last updated
- 2025-07-15
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05415007. Inclusion in this directory is not an endorsement.